Bradykinezi ve Parkinson hastalığında EEG desinkronizasyonunun bozulması.
Bradykinesia and impairment of EEG desynchronization in Parkinson's disease.
DOI: 10.1002/1531-8257(199905)14:3<423::aid-mds1006>3.0.co;2-vPMID: 10348464
Bradykinesia and impairment of EEG desynchronization in Parkinson's disease.
DOI: 10.1002/1531-8257(199905)14:3<423::aid-mds1006>3.0.co;2-vPMID: 10348464
Phosphorus magnetic resonance spectroscopy in multiple system atrophy and Parkinson's disease.
DOI: 10.1002/1531-8257(199905)14:3<430::aid-mds1007>3.0.co;2-sPMID: 10348465
Camptocormia (bent spine) in patients with Parkinson's disease--characterization and possible pathogenesis of an unusual phenomenon.
DOI: 10.1002/1531-8257(199905)14:3<443::aid-mds1009>3.0.co;2-gPMID: 10348467
Clinical rating of dyskinesias in Parkinson's disease: use and reliability of a new rating scale.
DOI: 10.1002/1531-8257(199905)14:3<448::aid-mds1010>3.0.co;2-0PMID: 10348468
Quetiapine for the treatment of drug-induced psychosis in Parkinson's disease.
DOI: 10.1002/1531-8257(199905)14:3<484::aid-mds1016>3.0.co;2-bPMID: 10348474
No increase of synthesis of (R)salsolinol in Parkinson's disease.
DOI: 10.1002/1531-8257(199905)14:3<514::aid-mds1023>3.0.co;2-2PMID: 10348481
Transient benefit of amantadine in Parkinson's disease: the facts about the myth.
DOI: 10.1002/1531-8257(199905)14:3<515::aid-mds1024>3.0.co;2-zPMID: 10348482
Parkinsonism from methanol poisoning: benefit from treatment with anti-Parkinson drugs.
DOI: 10.1002/1531-8257(199905)14:3<520::aid-mds1026>3.0.co;2-vPMID: 10348484
Central pontine and extrapontine myelinolysis presenting with parkinsonism in a patient with cystic fibrosis.
DOI: 10.1002/1531-8257(199905)14:3<523::aid-mds1027>3.0.co;2-pPMID: 10348485
Cinnarizine-induced parkinsonism: ten years later.
DOI: 10.1002/1531-8257(199905)14:3<534::aid-mds1032>3.0.co;2-zPMID: 10348490
Protease inhibitors enhance levodopa effects in Parkinson's disease.
DOI: 10.1002/1531-8257(199905)14:3<535::aid-mds1034>3.0.co;2-sPMID: 10348491
Neurogenetic correlates of Parkinson's disease: apolipoprotein-E and cytochrome P450 2D6 genetic polymorphism.
DOI: 10.1016/s0304-3940(99)00278-5PMID: 10353349
Kayıtlar bilimsel kaynaklardan alınır. Bibliyografik kayıt sayısı, Türkçe çeviri veya editoryal onay sayısı değildir.